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Summary 
Health indicators are measures of aspects of health and the health system that can be used to 
monitor the effectiveness and impact of the health system and of specific interventions to 
improve health and provide effective, accessible and quality health care.  
An initial set of indicators for asthma monitoring was developed in 2000 by the Australian 
Institute of Health and Welfare after asthma was made a National Health Priority Area in 
Australia in 1999. In 2004, the Australian Centre for Asthma Monitoring (ACAM) reviewed 
the proposed indicators under the auspices of the Australian System for Monitoring Asthma 
and published a set of recommended national asthma indicators. A detailed asthma data 
development plan was released in 2005, which outlined a range of projects that would 
address the data deficiencies that had been identified for the purposes of monitoring the 
recommended asthma indicators.  
This report reviews the outcomes of the indicator review, the lessons learnt through 
experience with various data sources, progress so far with asthma data development and 
suggests future directions for national asthma monitoring.  
What have we achieved so far? 
The asthma data development plan outlined a range of projects to address data deficiencies 
related to monitoring the recommended asthma indicators. These included: 
• developing a module of recommended survey questions; 
• data linkage; 
• validation of hospital and mortality data coding; 
• development of general practice data; 
• further investigation into dynamic health assessment to study health outcomes; 
• working with multiple cause of death and multiple diagnosis hospital data; and 
• input into national data development processes. 
ACAM has reported on the recommended asthma indicators for which national or state-
level data are available. Table 1 provides a summary of progress towards reporting and data 
development activities for each of the 24 recommended asthma indicators.  
Where to next? 
In this report, we explore future options including reviewing the list of asthma indicators. 
Future work will aim to provide a reduced set of indicators. This will be achieved by 
focusing on those indicators that provide useful information about asthma and that can 
guide policy and practice; and also by identifying opportunities to select one of several 
closely correlated indicators, hence removing redundant indicators. We expect that this list 
of core indicators will be the primary focus of ongoing monitoring and will be the basis for 
benchmarking standards in Australia and other countries. 
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Table 1: Reporting and development of national asthma indicators 
Indicator 
Reporting and whether or not recom-
mended definition used (yes 9 or no 8) Data development 
Prevalence of ever 
having doctor-diagnosed 
asthma 
Asthma in Australia 2003 
Asthma in Australia 2005 
Asthma in Australia: findings from 
the 2004–05 National Health Survey
9 
9 
9 
Recommended survey question: ‘Have you ever been 
diagnosed with asthma by a doctor or a nurse?’ 
Prevalence of current 
asthma (ever diagnosed 
plus symptoms or 
treatment in last 12 
months) 
Asthma in Australia 2003 
Asthma in Australia 2005 
Asthma in Australia: findings from 
the 2004–05 National Health Survey
9(a)
9(a)
8 
 
Recommended survey question: ‘Have you had symptoms 
of asthma or taken treatment for asthma in the last 12 
months?’ 
The ABS will include the recommended question in the 
2007–08 NHS after input from ACAM in the NHS 
consultation process.  
Prevalence of wheeze in 
the preceding 12 months 
Asthma in Australia 2003 
Asthma in Australia 2005 
9(a)
9(a)
Recommended survey question: ‘Have you had wheezing or 
whistling in your chest at any time in the last 12 months?’ 
Prevalence of airway 
hyperresponsiveness 
Asthma in Australia 2003 
Asthma in Australia 2005 
8 (b)
8 (b)
Further work is required to select the appropriate measure 
of airway hyperresponsiveness for surveillance purposes 
and to identify appropriate data sources. 
Impact of asthma on 
quality of life 
Reporting on several elements of 
this indicator in: 
Asthma in Australia 2003 
Asthma in Australia 2005 
Asthma in Australia: findings from 
the 2004–05 National Health Survey
 A number of questionnaires and individual questions have 
been recommended to report on this indicator. 
Index of asthma control Reporting on elements of this 
indicator in: 
Asthma in Australia 2005 
 Survey questions to monitor this indicator have been 
developed. 
Death rate for asthma, 
ages 5 to 34 years  
Asthma in Australia 2003 
Asthma in Australia 2005 
9 
9 
Death rate for asthma, all 
ages 
Asthma in Australia 2003 
Asthma in Australia 2005 
9 
9 
The NCCH proposed further study to improve the codes for 
asthma after a review of the ICD-10 and ICD-10-AM codes 
used for asthma found that there were limitations in the 
ability of these codes to provide information about the types 
of asthma that may have clinical relevance.  
Prevalence of smoking in 
people with asthma 
Asthma in Australia 2003 
Asthma in Australia 2005 
Asthma in Australia: findings from 
the 2004–05 National Health Survey
8 (c)
8 (c) 
8 (c)
Recommended survey question: ‘Do you smoke at least 
once a week?’  
Prevalence of smoking in 
the household where 
children with asthma 
reside 
Asthma in Australia 2003 
Asthma in Australia 2005 
Asthma in Australia: findings from 
the 2004–05 National Health Survey
8 (c)
8 (c) 
8 (c)
Recommended survey question: ‘Which of the following best 
describes your home situation?  
 – My home is smoke free 
 – People occasionally smoke in the house 
 – People frequently smoke in the house’ 
Proportion of schools 
using the Asthma 
Friendly Schools 
Program 
None reported  The proportion of pre-schools, child care centres and 
hospitals using nationally accredited asthma education 
programs is recommended for data development and 
monitoring in the future, when accredited programs have 
been implemented at a national level. 
Prevalence of 
occupational asthma 
None reported  Further work is required. A workshop to bring together 
experts in this area is planned in 2008 to consider options 
for data development. 
(continued) 
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Table 1 (continued): Reporting and development of national asthma indicators 
Indicator 
Reporting and whether or not recom-
mended definition used (yes 9 or no 8) Data development 
Rate of hospital 
separations for asthma 
Asthma in Australia 2003 
Asthma in Australia 2005 
Asthma and COPD among older 
people in Australia: deaths and 
hospitalisations 
9 
9 
9 
Patient days for asthma Asthma in Australia 2003 
Asthma in Australia 2005 
9 
9 
ACAM developed age-group-specific comparability factors 
using a dual coded data set which should be incorporated 
into the analysis of time series extending prior to 1998. 
Hospital re-admissions 
for asthma 
Asthma in Australia 2005 9(a)
 
Complexities in linking hospitalisation records for the same 
person to enable the observation of individuals, rather than 
overall hospital episodes, need to be overcome before this 
indicator can be monitored with a national data source. 
Number of individuals 
with separations for 
asthma 
None reported  Further work is required to establish data linkage models 
enabling this indicator to be measured. 
Rate of emergency 
department attendance 
for asthma 
Asthma in Australia 2003 
Asthma in Australia 2005 
9(a)
9(a)
Further development is required to establish a national 
database of emergency department attendances. 
Rate of asthma-related 
general practice 
encounters 
Asthma in Australia 2003 
Asthma in Australia 2005 
9 
9 
Options for new means of developing primary care data are 
being investigated. 
Rate of Asthma 3+ Visit 
Plan payments 
Asthma in Australia 2003 
Asthma in Australia 2005 
9 
9 
It is envisaged that this ‘program-specific indicator’ will be 
monitored for the duration of the Plan and its replacement, 
the Asthma Cycle of Care. 
Health-care visits for 
acute asthma 
None reported  Data sources require development. ACAM have 
recommended a series of survey questions: 
‘At any time in the last 12 months, was your asthma worse 
or out of control?’ If yes, 
‘In the last 12 months, how many times have you gone to a 
hospital or ED because your asthma was worse or out of 
control?’  
‘In the last 12 months, how many times have you consulted 
a GP or local doctor because your asthma was worse or out 
of control?’  
Proportion of people with 
asthma who have a 
written asthma action 
plan 
Asthma in Australia 2003 
Asthma in Australia 2005 
8 (c)
8 (c)
Recommended survey question: 
‘Do you have a written asthma action plan; that is, written 
instructions of what to do if your asthma is worse or out of 
control?’ 
Proportion of people with 
asthma who use 
preventers regularly 
Asthma in Australia 2003 
Asthma in Australia 2005 
Patterns of Asthma Medication Use 
in Australia 
Asthma in Australia: findings from 
the 2004–05 National Health Survey
8 
8 
8 
 
8 
Recommended survey question: ‘What are the names or 
brands of all the asthma medications you have used in the 
last 4 weeks?’ 
If any medications identified: ‘How often did you use {name 
of medication} in the last 4 weeks?’ (loop for each type of 
medication)  
(continued) 
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Table 1 (continued): Reporting and development of national asthma indicators 
Indicator 
Reporting and whether or not recom-
mended definition used (yes 9 or no 8) Data development 
Proportion of people with 
asthma who have had 
recent spirometry 
Asthma in Australia 2003 
Asthma in Australia 2005 
 
8 
8 
Development of a data source that is able to identify when 
spirometry is performed for the assessment of asthma, as 
opposed to other respiratory conditions, is needed if this 
indicator is to be monitored accurately. 
Expenditure on asthma Reporting on elements of this 
indicator in the following: 
Health Care Expenditure and the 
Burden of Disease Due to Asthma in 
Australia 
Asthma in Australia 2005 
 The ability to do a formal economic analysis of the 
expenditure on asthma is currently beyond the role of 
monitoring using routinely available data sources. Further 
development of this indicator is required. 
(a) State-level data reported using recommended definition. 
(b) Reported in association with prevalence of recent wheeze, not AHR alone. 
(c) Questions used to define current asthma not in line with the recommended definition.
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1 Introduction 
Health indicators are measures of aspects of health and the health system that can be used to 
monitor the effectiveness and impact of the health system and of specific interventions to 
improve health and provide effective, accessible and quality health care. Indicators may be 
disease-specific or focus on particular aspects of the health system. They summarise data 
that allow the regular reporting of disease levels, burden and trends and can be used to 
monitor changes over time. They are used to examine social, geographical and 
environmental differentials in the medical condition of interest. Indicators can identify 
problems that need action, but are usually unable to identify the reasons for the problem. 
Health indicators can monitor and help in the development of potential prevention and 
management strategies as well as tracking the impact of such strategies. In addition, 
indicators allow the evaluation of the impact of health policy and monitoring of progress 
towards targets. 
Asthma was made a National Health Priority Area in Australia in 1999. As a part of this 
action, there was recognition of the need for data to support an informed response to this 
disease. Therefore, a workshop conducted in August 2000 by the Australian Institute of 
Health and Welfare (AIHW 2000) developed a proposal for an initial set of indicators that 
could be useful for asthma monitoring. These were to be developed under the auspices of 
the Australian System for Monitoring Asthma (ASMA). 
The Australian Centre for Asthma Monitoring (ACAM) was established in 2002 as a 
collaborating unit of the Australian Institute of Health and Welfare (AIHW) to develop a 
system for population-based monitoring of asthma. Since its inception, ACAM has been 
overseen by the ASMA Steering Committee, which comprises members from the Australian 
Government Department of Health and Ageing (DoHA), the AIHW, the National Asthma 
Council Australia and the Asthma Foundations of Australia, as well as content area experts.  
In 2004, ACAM published a review of the proposed indicators (Baker et al. 2004), which 
assessed their feasibility and value and, where possible, provided data definitions and 
identified suitable data sources. In addition, the report proposed a number of new indicators 
for monitoring asthma and highlighted issues that needed to be resolved before appropriate 
indicators could be incorporated into an asthma-monitoring system.   
In parallel with this process, ACAM has also published several reports including Asthma in 
Australia 2003 and 2005 that used a wide range of administrative and research data 
collections from federal and state agencies and other sources, including industry, to publish 
a comprehensive record of asthma statistics (ACAM 2003; 2005a). A further key component 
of ACAM’s activities has been to undertake a program of data development to follow on 
from the indicator review and to develop the data sources for monitoring the recommended 
indicators. This was guided by ACAM’s data development plan, published in 2005 (ACAM 
2005b). 
This report reviews the outcomes of the indicator review, the lessons learnt through 
experience with various data sources, progress so far with asthma data development and 
suggests future directions for national asthma monitoring.  
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2 Status of current recommended 
asthma indicators 
This section will examine each of the asthma indicators that were recommended by ACAM 
in the technical review (Baker et al. 2004) and provide an update of how each is being 
monitored. 
2.1  Prevalence of ever having doctor-diagnosed 
asthma 
Four indicators were recommended for monitoring asthma prevalence. The first of these is 
the prevalence of ever having doctor-diagnosed asthma. This indicator is considered a 
‘supplementary’ indicator because it is necessary to measure this in order to measure the 
core prevalence indicator; ‘Prevalence of current doctor-diagnosed asthma’ (see 2.2). 
Operational definition 
Numerator: The number of people who report having ever been diagnosed with asthma 
by a doctor or nurse. 
Denominator: Australian population as at 30 June for same calendar year as numerator. 
Data sources 
This indicator can be monitored using data from the National Health Survey (NHS) and 
other state and local health surveys. 
Summary of monitoring activities 
The main source of data for this indicator has been the NHS, which is conducted every three 
years by the Australian Bureau of Statistics (ABS). Data have also been analysed from state 
Computer-Assisted Telephone Interview (CATI) surveys.  
ACAM have presented data for this indicator from the 2001 NHS, state CATI surveys and a 
number of other local area studies in both the Asthma in Australia 2003 (ACAM 2003) and 
Asthma in Australia 2005 (ACAM 2005a) reports. More recently, ACAM updated this 
information using the 2004–05 NHS in the report: Asthma in Australia: findings from the  
2004–05 National Health Survey (ACAM 2007a).  
While, as indicated in the technical review, it is possible to present these data by age and sex, 
state, rural and remote areas of residence, socioeconomic status (using residential 
postcodes), English-speaking background status (using country of birth) and Indigenous 
status, only breakdowns by age and sex have been recently published for this indicator 
(ACAM 2007a). This is because it is supplementary to the indicator ‘Prevalence of current 
asthma’. The latter indicator (see 2.2) is considered to have more relevance for informing 
policy and practice. 
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Summary of findings 
From the 2004–05 NHS, it was estimated that 3,979,486 Australians (20%) had ever been 
diagnosed with asthma by a doctor (ACAM 2007a). In addition, a number of state, territory 
and locally based surveys have estimated that, among adults, the prevalence of reporting 
ever having been diagnosed with asthma ranges from 17% to 25%, with most estimates 
between 19% and 21%. In four surveys conducted among children, estimates of the number 
who had ever been diagnosed with asthma ranged from 20% to 26% (ACAM 2005a).  
Data development issues 
As the indicator has an established national data source, there has been no further data 
development required. For monitoring this indicator, ACAM have recommended (ACAM 
2007c) that surveys use the following question: 
‘Have you ever been diagnosed with asthma by a doctor or a nurse?’. 
2.2  Prevalence of current asthma 
Operational definition 
Numerator: The number of people who report having ever been diagnosed with asthma 
by a doctor or nurse and who have experienced symptoms (wheeze, shortness 
of breath or chest tightness) of asthma or taken treatment for asthma in the 
last 12 months. 
Denominator: Australian population as at 30 June for same calendar year as numerator. 
Data sources 
Data relating to this indicator are available in the NHS and other state and local health 
surveys. 
Summary of monitoring activities 
At the time ACAM recommended this indicator, state CATI surveys were the most feasible 
source of data for this indicator. The NHS was limited in being able to monitor this indicator 
because the questions asked did not clearly identify those people who met the above 
operational definition.  
Within the NHS, the prevalence of current asthma was assessed by asking the following 
question among respondents who had indicated they had ever been diagnosed with asthma: 
‘Do you still get asthma?’ 
People who answered ‘yes’ to this question have been analysed (with qualification) as those 
with current asthma in ACAM reports (ACAM 2003; 2005a; 2007a). However, this is not 
completely consistent with the operational definition because this question does not 
establish that current asthma was based on self-reporting of asthma symptoms or treatment 
in the last 12 months.  
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Data from state CATI and other smaller surveys were also available, and some have been 
consistent with the ACAM operational definition. The results from these surveys have also 
been reported by ACAM (ACAM 2003; 2005a). However, there was variation in the survey 
methods used, the age ranges surveyed, the sample sizes and, most importantly, the way in 
which current asthma was measured. Therefore, it is necessary to examine the range of 
values obtained in these surveys to get an idea of the likely true prevalence of current 
asthma in the population. 
Both NHS and CATI survey data have been analysed by age, sex, state, remoteness and 
socioeconomic status. It should be noted that CATI surveys have sampled insufficient 
numbers of Aboriginal and Torres Strait Islander Australians to yield reliable estimates of 
prevalence in this population—more reliable information has generally been obtained from 
the ABS National Aboriginal and Torres Strait Islander Health Survey. However, as with the 
NHS, this survey has also not applied the recommended ACAM operational definition. 
Summary of findings 
In the 2004–05 NHS, 2,010,212, or 10.3% of the population, stated that they ‘still get asthma’ 
(ACAM 2007a). Among other state and locally based surveys, the prevalence of current 
asthma among adults has ranged from 9% to 15%, with most estimates falling between 10% 
and 12%. The proportion of children with current asthma ranged between 14% and 16% 
(ACAM 2005a). These estimates are high by international standards.  
Several findings have been consistent across the range of data. Among children, boys have a 
higher rate of asthma than girls. However, after the teenage years, asthma is more common 
in women than in men. The prevalence of asthma is higher among Aboriginal and Torres 
Strait Islander people than among other Australians, particularly women aged 35 years and 
over. It is also lower among those from non-English-speaking backgrounds. 
Data development issues 
The major data development issue for this indicator is to establish national data that are 
based on a consistent and meaningful definition of current asthma. This has been an 
important area of survey question development and a question to monitor current asthma 
that had been recommended in ACAM’s review of indicators, has been field-tested and 
recommended for use among people who indicated they had ever been diagnosed with 
asthma (ACAM 2007c): 
‘Have you had symptoms of asthma or taken treatment for asthma in the last 12 months?’  
Through its NHS consultation process, the ABS have indicated that they will include the 
recommended question in the 2007–08 NHS to monitor current asthma. The previous 
question used by the NHS will also be asked, so that the difference in estimates of current 
asthma obtained by each question can be evaluated. 
Application of this recommended definition for identifying people with current asthma is 
also important for many of the other indicators which are monitored among the subset of 
Australians with current asthma. 
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2.3  Prevalence of recent wheeze  
Operational definition 
It is proposed that this indicator be monitored separately in children and adults. 
Numerator: The number of children/adults (age 18–44 years) who report wheeze or 
whistling in the chest in the previous 12 months. 
Denominator: Australian population as at 30 June for same calendar year as numerator.  
Data sources 
This indicator can be monitored using data from state and local health surveys; however, 
there is no single, national data source. 
Summary of monitoring activities 
Data relating to this indicator from a range of surveys and studies were reported in Asthma 
in Australia 2003 (ACAM 2003).  
While some data can be analysed by age and sex, state, remoteness, socioeconomic status 
(using postcode of residence) and English-speaking status, these disaggregations have not 
been included in ACAM reports to date as, similarly to the ‘Prevalence of ever asthma’ (2.1), 
it is not considered to have key importance for policy and practice compared to the 
‘Prevalence of current asthma’ indicator (2.2). 
Summary of findings 
The prevalence of recent wheeze is substantially higher than the prevalence of asthma, 
particularly among children. Between 1992 and 2002, estimates of current wheeze in studies 
of children ranged from 16% to nearly 34%. Among adults during the 1990s these estimates 
ranged from 22 to 26%. The age ranges sampled in these surveys varied widely and the 
extent to which this higher prevalence of wheeze represents undiagnosed asthma, as 
opposed to non-asthma, viral-associated wheeze, cannot be ascertained from the available 
data (ACAM 2003). 
Data development issues 
There has been no further data development required for this indicator. For monitoring this 
indicator, ACAM have recommended that surveys use the following question: 
‘Have you had wheezing or whistling in your chest at any time in the last 12 months?’ (ACAM 
2007c). 
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2.4  Prevalence of airway hyperresponsiveness 
Operational definition  
This indicator was recommended by ACAM because it provides an objective measure of 
asthma prevalence in contrast with the three previous measures, which are all based on self-
reporting. An operational definition for this indicator has not been established. 
Data sources 
No national data source has been identified, although some local and regional data 
collections have been recognised.  
Summary of monitoring activities 
ACAM have cited data from the Belmont (Toelle et al. 2004) and Wagga Wagga (Downs et 
al. 2001) studies, which used airway hyperresponsiveness to indicate the prevalence of 
current asthma in children. In Asthma in Australia 2003, data from these studies on the 
presence of both airway hyperresponsiveness and self-reported wheeze in the last 12 months 
were used to define current asthma. 
Summary of findings 
As previously stated, the availability of data for this indicator is extremely limited. The 
prevalence of both wheeze in the last 12 months and airway hyperresponsiveness among 
children in the Belmont area of coastal New South Wales was 11.3% in 2002 (Toelle et al. 
2003 cited in Asthma in Australia 2003).  
Data development issues 
Further work is required to select the appropriate measure of airway hyperresponsiveness 
for surveillance purposes and to identify appropriate data sources. For further information 
see Section 3.4. 
2.5  Impact of asthma on quality of life 
Operational definition  
The proportion of people with current asthma who report having poor health-related quality 
of life. 
It is proposed that this indicator be monitored separately in adults and children and with 
consideration for the domains of health-related quality of life. This is discussed in the report: 
Measuring the impact of asthma on quality of life in the Australian population (ACAM 2004). 
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Data sources 
Data relating to this indicator are available in the NHS and other state/territory and local 
health surveys. 
Summary of monitoring activities 
Some measures relevant to quality of life were reported by ACAM in Asthma in Australia 
2003 and 2005 (ACAM 2003; 2005a) and from the 2004–05 NHS (ACAM 2007a). These 
include self-assessed health status, levels of psychological distress, days off work or study 
and sick days due to asthma. 
Summary of findings 
Findings from survey data consistently find that people with asthma rate their health worse 
than people without asthma. In the 2004–05 NHS, fewer people with current asthma (42%) 
rated their health as ‘excellent’ or ‘very good’ than people without current asthma (52%) 
(ACAM 2007a), and more rated their health as ‘poor’ (28%) than people without current 
asthma (14%). However, based on data from the 2004–05 NHS, people with current asthma 
were more likely to rate their health better than their counterparts in the 2001 NHS. 
Data from the 2004–05 NHS also identified that a greater proportion of people with asthma 
have days away from work or study (16.6%) than people without asthma (10.7%) or other 
days of reduced activity (19% and 10%, respectively). Again, these proportions had 
decreased for people with current asthma compared with those reported in the 2001 NHS, 
suggesting some improvement in these impacts over time. 
People with asthma also generally scored higher on the psychological distress scale and, in 
the 2004–05 NHS, people with current asthma were 1.9 times more likely to have high or 
very high psychological distress than people without current asthma (ACAM 2007a). 
Data development issues 
In 2004, ACAM published its report Measuring the impact of asthma on quality of life in the 
Australian population (ACAM 2004). The purpose of this report was to further develop an 
approach to monitoring the effects of asthma on quality of life. This report reviewed and 
identified a range of questionnaire-based measures that could be used to assess the impact of 
asthma on quality of life. Further development occurred in the process undertaken by 
ASMA to develop survey questions for monitoring asthma indicators (Section 3.1). ACAM 
have recommended a number of questionnaires and individual questions to report on this 
indicator (ACAM 2007c). 
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2.6  Index of asthma control 
Operational definition  
This is a composite indicator comprising measures of asthma severity and control among 
people with current asthma. 
Data sources 
There is currently no identified national data source. However, some data relating to this 
indicator are available in state/territory and local health surveys and the situation will 
improve if there is implementation of the ACAM recommendations for a module of survey 
questions to monitor asthma indicators (ACAM 2007c). 
Summary of monitoring activities 
Some data were reported from state/territory and local surveys in Asthma in Australia 2005 
for the proportion of adults with current asthma whose sleep was disturbed by asthma. 
Evaluation of sleep disturbance has been recommended as a component of this index (see 
below). 
Summary of findings 
Approximately 40% of adults with current asthma report disturbed sleep due to their 
asthma in the last month. Among children with current asthma the interruption is more 
prevalent, with almost half reporting one or more nights of disturbed sleep in the last month 
(ACAM 2005a). 
Data development issues 
Survey questions to monitor this indicator have been developed as a part of the ASMA data 
development activities (see Section 3.1). Recommended measures include:  
• proportion of people who experience severe enough wheezing to limit speech  
• frequency of asthma symptoms in the last 4 weeks  
• proportion of people with asthma who have been woken from sleep due to asthma 
symptoms in the preceding week. 
• rate of use of short-acting bronchodilator medication 
These have been recommended in the module of survey questions to monitor asthma 
indicators (provided in Appendix A). It is expected that the implementation of the 
recommended asthma question module (ACAM 2007c) would provide data for this 
indicator. 
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2.7  Death rate for asthma, all ages 
Operational definition  
Numerator: Total number of death occurrences in Australia assigned to ICD-9 code 493 or 
ICD-10 code J45 or J46 as underlying cause of death for a particular calendar 
year. 
Denominator: Australian population as at 30 June for same calendar year as numerator. 
Data sources 
National data for this indicator are available in the National Mortality Database.  
Summary of monitoring activities 
This indicator was included in the Asthma in Australia 2003 and 2005 reports. Time trends 
since 1979, using 3-year moving averages, and seasonal variations were reported. Data 
where deaths occurred in people aged five years and over from the most recent five years 
were disaggregated by sex, age, state or territory, English-speaking background status, 
socioeconomic status and remoteness of residence.  
Summary of findings 
The death rate due to asthma in Australia is moderately high by international standards. 
However, trends in asthma deaths have declined since the most recent peak in 1989. There 
were 318 deaths in which asthma was the underlying cause in 2004—representing 0.2% of all 
deaths in that year (ABS 2006). 
Death rates are higher among people aged 35 to 64 years who live in outer regional and 
remote areas, people of lower socioeconomic status and older people (ACAM 2005a). From 
1992, mortality rates have been higher in females than males. 
Data development issues 
The accuracy of coding will impact on the accuracy of mortality data. This is discussed 
further in Section 3.3. Validation of coding in all ages, particularly in older age groups, is 
needed.  
Analysis has not been carried out using the Aboriginal and Torres Strait Islander status 
variable as it is not sufficiently reliable in most states. At this stage, data for South Australia, 
Western Australia and the Northern Territory can be considered sufficiently reliable from 
1990 and Queensland from 1998. Trend analysis of Aboriginal and Torres Strait Islander 
status data is not considered reliable. 
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2.8  Death rate for asthma, persons aged 5–34 
years  
Operational definition  
Numerator: Total number of death occurrences in Australia (among people aged 5 to  
34 years) assigned to ICD-9 code 493 or ICD-10 code J45 or J46 as underlying 
cause of death for a particular calendar year. 
Denominator: Australian population (aged 5 to 34 years) as at 30 June for same calendar year 
as numerator. 
Data sources 
National data for this indicator are available in the National Mortality Database.  
Summary of monitoring activities 
This indicator was included in Asthma in Australia 2003 and 2005 (ACAM 2003; ACAM 
2005a). Time trends since 1979, using 3-year moving averages, and seasonal variation were 
reported. Data from the most recent five years were disaggregated by sex, English-speaking 
background status, socioeconomic status and remoteness of residence.  
Summary of findings 
Deaths due to asthma among people aged 5 to 34 years have declined since the most recent 
peak in 1986, although the decline is less marked than that observed among all ages. In 2004 
there were 31 deaths due to asthma in people aged 5 to 34 years (0.37 per 100,000 population, 
95% confidence interval (CI): 0.26–0.51) (ABS 2006). 
Data development issues 
These are the same as those described under the previous section (2.7). This indicator, which 
includes only the subset of people aged 5 to 34 years, is considered more specific for 
monitoring asthma than using all ages because there may be diagnostic confusion and 
misclassification with chronic obstructive pulmonary disease (COPD) in older age groups. 
No additional data development issues have been identified. 
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2.9  Prevalence of smoking in people with asthma 
Operational definition 
Numerator: The number of people aged 18 years and over who have current asthma and 
who smoke any tobacco product weekly or more frequently. 
Denominator: The estimated number of Australians aged 18 years and over with current 
asthma. 
Data sources 
Data relating to this indicator are available in the NHS and other state and local health 
surveys. 
Summary of monitoring activities 
The NHS was limited in being able to monitor this indicator because the questions asked did 
not clearly identify those people who met the above operational definition. However, the 
NHS includes the question: 
‘Do you currently smoke?’  
ACAM has used this question in conjunction with those used to identify current asthma to 
report on people with current asthma who smoke from the 2001 and 2004–05 NHS. Despite 
not being completely consistent with the recommended operational definition, these data 
were used to present information relevant to this indicator in Asthma in Australia 2003 and 
2005 and the report Asthma in Australia: findings from the 2004–05 National Health Survey. Data 
were disaggregated by age, sex and socioeconomic status, with additional comparisons 
drawn between those with and without current asthma and those who were current and  
ex-smokers. Further data disaggregations, such as remoteness, English-speaking background 
status and Indigenous status have not been undertaken because of small numbers. 
Summary of findings 
In the 2004–05 NHS, it was reported that 24.5% (95% CI 23.5–28.2%) of people with current 
asthma were current smokers. This rate was not significantly different from that observed 
among people without asthma. Among people with asthma, those who are younger and live 
in localities that are relatively socioeconomically disadvantaged are most likely to smoke. 
Data development issues 
It is noteworthy that the NHS question used by ACAM to identify current smoking does not 
define people who smoke weekly or more frequently. In addition, this indicator requires the 
identification of people with current asthma and, as noted in Section 2.2, the questions used 
from the NHS do not clearly identify current asthma consistently with the operational 
definition for that indicator.  
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In the 2004–05 NHS, people who answered ‘Yes’ when asked if they currently smoke were 
asked an additional question: 
‘Do you smoke at least once a week?’ 
This question was endorsed in the ASMA survey question development process and can be 
used in the future to identify individuals who meet the operational definition criteria for a 
current smoker (ACAM 2007c). Furthermore, as already noted, the ABS indicated that they 
will modify their questions to identify current asthma to be consistent with the ASMA 
operational definition in the 2007–08 NHS. With these changes, the NHS will be a feasible 
source of national data for monitoring this indicator in accordance with its recommended 
operational definition.  
2.10  Prevalence of smoking in the household where 
children with asthma reside 
Operational definition  
Numerator: The number of people aged less than 15 years with (a) current asthma or  
(b) wheeze in the previous 12 months and who live in a household where one 
or more regular smokers resides. 
Denominator: The number of people aged less than 15 years with (a) current asthma or  
(b) wheeze in the previous 12 months. 
Data sources 
Data relating to this indicator are available in the NHS and other state and local health 
surveys. 
Summary of monitoring activities 
National data relating to this indicator have been examined from the NHS by analysing data 
for children aged 0 to 14 years with current asthma who live with a current smoker (current 
smokers were identified in the NHS, see 2.9). These data have been presented in Asthma in 
Australia 2003 and 2005 and the report Asthma in Australia: findings from the 2004–05 National 
Health Survey. Data were disaggregated by age, sex and socioeconomic status, with 
comparisons of the proportion of children with and without asthma. Further disaggregations 
were not undertaken due to small numbers. 
Information was also published from two state CATI surveys (New South Wales and 
Western Australia) that related to this indicator but which focussed on whether the child 
lived in a household in which smoking occurred. This issue is explored further below. 
Summary of findings 
Similar proportions of children with and without asthma live with one or more regular 
smokers (39.1% and 36.2%, respectively). Of these, 11% and 9.4%, respectively, resided in 
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homes in which smoking occurred indoors (ACAM 2007a). The higher rate of household 
exposure to smokers is most evident in more socioeconomically disadvantaged areas. 
Data development issues 
While operational definitions provided in the review of asthma indicators (Baker et al. 2004) 
defines passive smoke exposure as living with a smoker, more recent recommendations are 
that information should focus on whether a child lives in a household in which smoking 
occurs (ACAM 2007c). Some CATI surveys currently collect data using the question: 
‘Which of the following best describes your home situation?  
–My home is smoke free 
–People occasionally smoke in the house 
–People frequently smoke in the house’ 
This question has been recommended for this indicator (ACAM 2007c). Currently it has been 
included in South Australia and New South Wales health surveys. Revisions to the 
operational definition may also be appropriate. For example, it may be more meaningful to 
monitor the number of children with current asthma who live in houses in which smoking 
occurs as opposed to those who reside with adults who currently smoke. Also, it may be 
relevant to quantify the extent of exposure to passive smoke.  
2.11  Prevalence of occupational asthma 
Operational definition 
Numerator: The total number of asthma cases attributed to exposure at work at a given 
time within the survey population. 
Denominator: Denominator populations for the two surveys. 
Data sources 
No national or reliable state/local data sources have been identified.  
Summary of monitoring activities 
There is no ongoing data source for reporting on this indicator. Various ad hoc collections 
provide some data to report on the prevalence of occupational asthma at the present time.  
Summary of findings 
There has been no information reported for this indicator to date. A review of the literature 
on this topic has been carried out under the auspices of the Australian System for 
Monitoring Asthma in 2006, but this is yet to be published.  
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Data development issues 
This is an important area for asthma monitoring because it concerns cases of potentially 
preventable asthma. However, it is also very difficult to ascertain these cases in data that can 
be used for monitoring purposes. 
The review of asthma indicators (Baker et al. 2004) provided an evaluation of available data 
that included two ad hoc surveys carried out in Victoria and New South Wales and a 
voluntary reporting scheme: Surveillance of Australian workplace Based Respiratory Events 
(SABRE) that operates in New South Wales, Victoria and Tasmania. All of these data sources 
are prone to selection bias arising from low response rates in surveys and low reporting 
rates to SABRE. The method of attribution of asthma to an occupational exposure is also 
indirect.  
Data development is required to enhance the currently available data on the incidence of 
occupational asthma. Currently, a workshop to bring together experts in this area is planned 
in 2008 to consider options for further data development. It seems likely that the definition 
will need to be revised. 
2.12  Proportion of schools using the Asthma 
Friendly Schools program 
Operational definitions  
Numerator: Number of schools recognised as using the Asthma Friendly Schools 
program. 
Denominator: Total number of schools in Australia. 
 
Numerator: Number of students in schools recognised as using the Asthma Friendly 
Schools program. 
Denominator: Total number of students in Australian schools. 
Data sources 
Data are recorded at state level by the individual Asthma Foundations after a follow-up to 
check that the essential criteria for Asthma Friendly Schools have been met. However, there 
are differences in the way compliance with the criteria for accreditation is assessed. While 
Asthma Foundations in some states require evidence to support the claim that the 
accreditation criteria have been met, in other states accreditation is awarded on the basis of 
the signed statement of compliance from the school principal. 
Summary of monitoring activities 
This indicator has not been reported on as further data development is required before this 
can be reported using a national data source.  
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The proportion of schools and students can be disaggregated into primary and secondary, as 
well as the type of school (government, Catholic or independent). 
Individual schools will be disaggregated by remoteness classification. 
Schools and students will also be analysed by state, as there have been slight variances in the 
rollout of the Asthma Friendly Schools program in each state due to differences in the time 
frames and methods of approaching the schools. 
Summary of findings 
No information on this indicator has been reported in any ACAM reports. 
Data development issues 
The proportion of pre-schools, child care centres and hospitals using nationally accredited 
asthma education programs is recommended for data development and monitoring in the 
future, once accredited programs have been implemented at a national level. The relevance 
of this indicator as a core asthma indicator will be reviewed in future work. 
2.13  Hospital separation rate for asthma 
Operational definition 
Numerator: Total number of hospital separations from Australian private and public 
hospitals assigned to a principal diagnosis of ICD-9-CM code 493 or  
ICD-10-AM code J45 or J46 for a particular calendar year. 
Denominator: Australian population as at 30 June for same calendar year as numerator. 
Data sources 
State/territory hospital separations data are compiled from all public general and 
psychiatric hospitals, private hospitals and private day surgery facilities. These data are 
considered to be close to complete and are, therefore, largely representative of the 
population who use hospital services. Each state/territory contributes an agreed subset of 
variables from their hospital data collections for inclusion on the National Hospital 
Morbidity Database (NHMD). Therefore, the NHMD held at the AIHW provides a national 
source of data to monitor this indicator.  
Summary of monitoring activities 
This indicator has been reported in Asthma in Australia 2003 and 2005 (ACAM 2003; 2005a). 
Time trends since 1993 and seasonal variation were reported. Data from the most recent year 
were disaggregated in these reports by age, sex, English-speaking background status, 
socioeconomic status, remoteness and Indigenous status. Information on the number of 
separations for asthma among people aged 55 years and over was also reported in Asthma 
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and chronic obstructive pulmonary disease among older people in Australia: deaths and 
hospitalisations (ACAM 2006). 
Summary of findings 
There are approximately 40,000 hospital separations each year in which the principal 
diagnosis is asthma. The highest hospitalisation rates have occurred among children, 
particularly those aged less than 5 years, and these rates decreased by 43% between 1993–94 
and 2003–04. Among adults, hospitalisation rates have also decreased by 17% over this time.  
Among people aged 65 years and over, rates of hospitalisation for asthma are highest in the 
winter months, whereas among children, the peaks occur in February and May.  
Among children, boys have higher rates of hospitalisation for asthma than girls, which 
reflects the higher prevalence of asthma in boys. However, this trend is reversed after the 
age of 15 years when more females than males are admitted to hospital for asthma. Rates of 
hospitalisation are higher among people living in more remote areas, Indigenous 
Australians and people living in more socioeconomically disadvantaged areas (ACAM 
2005a). 
Data development issues 
Changes to coding practice will affect the quality of this indicator. Validation studies have 
demonstrated that diagnostic accuracy is higher in younger age groups. The impact of 
changes to ICD coding has been less well studied. A dual coded data set has been used to 
quantify age-group-specific comparability factors. These need to be incorporated into the 
analysis of time series extending prior to 1998. This is also discussed in Section 3.3. 
2.14  Hospital patient days for asthma  
Operational definition  
Numerator: Total number of patient days from Australian private and public hospitals 
assigned to ICD-9-CM code 493 or ICD-10-AM code J45 or J46 for a particular 
calendar year. 
Denominator: Australian population as at 30 June for same calendar year as numerator. 
Data sources 
As for the previous indicator (2.13), the NHMD held at the AIHW is the best data source for 
monitoring hospital patient days for asthma. 
Summary of monitoring activities 
Included in the NHMD are both admission date, separation date and the total number of 
days hospitalised. This indicator has been monitored using these variables in both Asthma in 
Australia 2003 and 2005 (ACAM 2003; 2005a). Time trends in the total number of hospital 
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days were provided since 1993, and data were disaggregated by age, sex, English-speaking 
backgrounds status, socioeconomic status, remoteness, and Indigenous status. 
Summary of findings 
The overall number of hospital bed-days occupied by patients with asthma has declined by 
49% between 1993–94 and 2003–04. The reduction in hospital bed-days, combined with the 
decrease in hospital separations for asthma, has resulted in a fall in the average length of 
stay for all age groups from 2.9 days to 2.2 days (ACAM 2005a). 
Data development issues 
These are the same as those described under Section 2.13.  
2.15  Hospital re-admissions for asthma within  
28 days 
Operational definition 
Numerator: Number of people discharged from hospital with a principal diagnosis of 
asthma (ICD-10-AM code J45 or J46) who are re-admitted within 28 days to 
the same hospital with a diagnosis of asthma.  
Denominator: (1) number of hospital separations for asthma in the year. 
  (2) Australian population as at 30 June for same calendar year as numerator. 
Data sources 
Currently, state hospital data collections, particularly in New South Wales, Victoria and 
Western Australia, are the most feasible data sources for this indicator. In future, the NHMD 
may be used as a data source. 
Summary of monitoring activities 
Data relating to this indicator were reported for the first time in Asthma in Australia 2005 
(ACAM 2005a). However, reporting was limited to two states: namely New South Wales and 
Victoria. These data were disaggregated by age and sex, and represent 60% of the Australian 
population.  
An extension to this indicator was foreshadowed in the indicator review (Baker et al. 2004). 
This was to include both hospital emergency department visits and admissions to hospital to 
ascertain overall ‘re-attendances’ at hospital for asthma. This was also reported in Asthma in 
Australia 2005 (ACAM 2005a) for Victoria and New South Wales by age and sex. 
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Summary of findings 
Analysis of data for New South Wales and Victoria has shown that, following a 
hospitalisation for asthma, 5% of people are re-admitted to hospital for asthma within  
28 days. The highest rate of re-admissions is among people aged 15 to 64 years and re-
admission rates are higher in females than males. 
Data development issues 
Currently, this indicator has only been monitored in two states using state-based data 
sources. There are a number of complexities that have to be overcome before it is possible to 
report on this indicator with a national data source. In Australia, hospitalisation data are 
based on hospital admissions, rather than the individuals hospitalised. Therefore, 
hospitalisation records for the same person need to be linked to be able to track individuals 
rather than overall hospital episodes.  
For national monitoring purposes, it is desirable to identify a single national source of data. 
The most likely source is the NHMD because it contains data routinely forwarded from all 
states and territories. However, the data forwarded are very limited, and data development 
is required in order to determine the feasibility of linkage within this data set. This is 
discussed further in Section 3.2. 
2.16  Number of individuals with separations for 
asthma 
Operational definition 
Numerator: Total number of individuals who had hospital separations from Australian 
private and public hospitals assigned to a principal diagnosis of ICD-9-CM 
code 493 or ICD-10-AM code J45 or J46 for a particular calendar year. 
Denominator: Australian population as at 30 June for same calendar year as numerator. 
Data sources 
Currently, state hospital data collections, particularly in New South Wales, Victoria and 
Western Australia, are the only feasible data sources for this indicator. In future, it is 
envisaged that the NHMD may be used as a data source. 
Summary of monitoring activities 
This indicator has not been monitored as further data development is required before a 
national data source becomes available. 
Summary of findings 
This indicator has not been reported in any ACAM publications to date. 
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Data development issues 
Data development will be required to establish data linkage models to enable this indicator 
to be measured. It is most likely that this linkage will be developed once it is possible to also 
measure hospital re-admissions for asthma (see Section 2.15).  
2.17  Rate of emergency department attendance for 
asthma 
Operational definition 
Numerator: Number of hospital emergency department attendances with a principal 
diagnosis of asthma (ICD-9 code 493 or ICD-10 codes J45 or J46) for a 
particular calendar year 
Denominator: Australian population as at 30 June for same calendar year as numerator. 
Data sources 
Currently, state data collections, particularly in New South Wales, Victoria and partial data 
from Western Australia, are the only feasible data sources for this indicator.  
Summary of monitoring activities 
Data relating to this indicator were reported in Asthma in Australia 2003 and 2005 (ACAM 
2003; 2005a). However, reporting was limited to two states: New South Wales (both reports) 
and Victoria (2005 report only). Time trends and seasonal variation over the period 1999 to 
2004 were reported and data were disaggregated by age, sex, attendance outcome (for 
example, hospital admission), triage category and socioeconomic status. 
Summary of findings 
The highest rate of emergency department visits for asthma occurs among children aged 0 to 
4 years. Children in this age group, along with the elderly, are most likely to be admitted to 
hospital as a result of going to the emergency department (ACAM 2005a). Visits to 
emergency departments peak among children in mid February, while, among adults, the 
peaks occur during the winter months. 
Data development issues 
Ideally, a national database of emergency department attendances would be developed. 
Further development is needed to determine the feasibility of such an undertaking. 
However, at the time of this review, there were no plans for such development to occur. 
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2.18  Rate of asthma-related general practice 
encounters 
Operational definition 
Numerator: Estimated proportion of general practice encounters where asthma was 
managed (for designated year) multiplied by the number of claims for 
Medicare reimbursement for Professional Attendances group A1 and A2  
(for that year). 
Denominator: Australian population as at 30 June for same calendar year as numerator. 
Data sources 
This indicator has been predominantly monitored by ACAM using the survey known as 
BEACH (Bettering the Evaluation And Care of Health). This survey invites a sample of  
20 general practitioners (GPs) per week to complete the survey for 100 consecutive patient 
encounters. The findings can then be applied to total Medicare Benefits Scheme claims for 
GPs to extrapolate on the national patterns of general practice encounters. 
Summary of monitoring activities 
BEACH data were used to monitor this indicator in Asthma in Australia 2003 and 2005 
(ACAM 2003; 2005a). Time trends in BEACH data have been reported from 1998 and data 
have been disaggregated by age, sex, socioeconomic status, and remoteness. In addition to 
rates being reported as a rate of the estimated resident population, rates were also reported 
as a rate of total general practice encounters. 
Summary of findings 
During the period 1998–99 to 2003–04, the rate of general practice encounters for asthma 
decreased from 3.1% to 2.5% of all general practice encounters. Boys aged 0 to 4 years have 
the highest rate of asthma-related general practice encounters. 
Data development issues 
There are limitations to this data source because of the low participation rates by GPs (28.1% 
in 2004–05) in the BEACH program. Although post-stratification weighting is used to adjust 
for differences between the sample and the GP population, the sample may not be 
representative of general practice and, therefore, data on morbidity may not be an accurate 
reflection on the current situation in general practice. However, BEACH still remains the 
most reliable and representative source for these data. 
The future of the BEACH data collection is currently being reviewed and options for new 
means of developing primary care data are being investigated. 
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2.19  Rate of Asthma 3+ Visit Plan payments 
Operational definition  
Numerator: Number of claims for completed Asthma 3+ Visit Plan Practice Incentive 
Program Payments. 
Denominator: Australian population as at 30 June for same calendar year as numerator.  
Data sources 
The Asthma 3+ Visit Plan Practice Incentive Program (PIP) was replaced by the Asthma 
Cycle of Care in November 2006. The Program is funded by the Australian Government and 
aims to improve general practice care for patients with moderate or severe asthma. It entails 
the development and ongoing review of an asthma management plan over at least two 
general practice visits (DoHA 2002; 2003). Data from the Asthma Cycle of Care Program are 
reported through Medicare Australia, based on claims for remuneration for structured 
asthma review visits made by GPs. 
Summary of monitoring activities 
ACAM have summarised data reported through Medicare Australia by age and sex, and by 
state/territory of residence in Asthma in Australia 2003 and 2005 (ACAM 2003; 2005a). In 
these reports, ACAM also presented the rate of claims using ‘people with current asthma’ as 
the denominator. 
Summary of findings 
Since being introduced in 2001, it is estimated that 3.9% of people with current asthma, or 
12.9% of people with moderate or severe asthma, have used the Asthma 3+ Visit Plan. 
Children and older adults were the most likely to access it, and young adults aged 15 to  
34 years were least likely (ACAM 2005a). 
Data development issues 
This indicator was proposed as a temporary, ‘program-focused’ indicator to report on the 
uptake of the Asthma 3+ Visit Plan PIP. With the recent changes, the number of claims for— 
the replacement program—the Asthma Cycle of Care PIP, will be measured for the duration 
of the Program, using total counts, cumulative counts and rates. 
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2.20  Health-care visits for acute episodes of asthma 
Operational definition 
This is a composite indicator that would include rates of general practice visits for acute 
episodes of asthma as well as emergency department visits and hospitalisations for asthma. 
Numerator: Number of acute asthma-related general practice visits, number of emergency 
department visits with a principal diagnosis of asthma (ICD-9 code 493 and 
ICD-10 codes J45 and J46) and hospital separations with a principal diagnosis 
of asthma (ICD-9-CM code 493 and ICD-10-AM codes J45 and J46). 
Denominator: Australian population as at 30 June for same year as numerator. 
Data sources 
Data relating to this indicator are available in the NHS and other state and local health 
surveys. There may also be other sources of data that could inform this indicator, 
particularly hospitalisation, emergency department and general practice data. 
Summary of monitoring activities 
Data are only complete for the hospital separation component of this indicator and further 
development is required before it can be monitored. 
Summary of findings 
No information has been reported on this indicator in any ACAM reports to date. 
Data development issues 
While existing administrative data may be useful for informing this indicator, it is more 
likely that it will be monitored using self-reported data from health surveys. The data 
sources for this indicator require development. ACAM have recommended questions to 
monitor this indicator in its module of survey questions to monitor national asthma 
indicators (ACAM 2007c) which are summarised in Appendix A of this report. 
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2.21  Proportion of people with asthma who have a 
written asthma action plan 
Operational definition 
Numerator: Number of people with current asthma who have an individualised, written 
asthma action plan incorporating information on how to recognise the onset 
of an exacerbation of asthma and information on what action to take in 
response to that exacerbation, developed in consultation with a health 
professional. 
Denominator: Total population of people with asthma. 
Data sources 
Data relating to this indicator are available in the NHS and other state and local health 
surveys. However, these data often fail to adequately define the criteria defining a written 
asthma action plan as stated in the above operational definition.  
There may also be other sources of data that could inform this indicator, particularly from 
general practices. 
Summary of monitoring activities 
Among people with current asthma, the NHS collected information about possession of a 
written asthma action plan in the 2001 and 2004–05 surveys. These data have been analysed 
and presented in Asthma in Australia 2003 and 2005 (ACAM 2003; 2005a) and the report 
Asthma in Australia: findings from the 2004–05 National Health Survey (ACAM 2007a). Data 
were disaggregated by age, sex, state, remoteness, socioeconomic status and Indigenous 
status. Data have not been disaggregated by English-speaking background status due to 
small numbers. 
Data on rates of possession of action plans were also compiled from state surveys (New 
South Wales, South Australia and ‘Eastern’ Australia) in Asthma in Australia 2003 and 2005 
(ACAM 2003; 2005a). 
Summary of findings 
Less than a quarter (23%) of people with current asthma have a written asthma action plan 
(ACAM 2007a). The possession of asthma action plans increased in the early 1990s and then 
decreased until 2002 (ACAM 2005a). However, the latest figures from the 2004–05 National 
Health Survey indicate a small increase in the rate of possession. Adults, particularly men, 
and the elderly, and persons living in less well-off areas are least likely to have a written 
asthma action plan. 
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Data development issues 
The questions used to accurately define individuals who possess a written asthma action 
plan as described in the above operational definition have been the subject of survey 
question development. Reliable questions to monitor this indicator have been suggested in 
the recommended module of survey questions to monitor national asthma indicators 
(ACAM 2007c). Further data development for this indicator may occur using general 
practice data (see Section 3.4). 
2.22  Proportion of people with asthma who use 
‘preventers’ regularly 
Operational definition 
Numerator: Number of people with current asthma for whom preventers are indicated 
and who report using a ‘preventer’ medication daily. 
Denominator: Number of people with current asthma for whom preventers are indicated 
(that is, who meet the National Asthma Council Australia criteria for 
preventer medication or similar). 
Data sources 
Data relating to this indicator are available in the NHS and in state/territory CATI health 
surveys. Data are also available form the Pharmaceutical Benefits Scheme (PBS) and IMS 
Health pharmaceutical supply data. However, these data do not show whether the 
medications were used for asthma or for other obstructive respiratory diseases. 
Summary of monitoring activities 
Information relating to this indicator using data from the 2001 NHS, the PBS and IMS Health 
was published in Asthma in Australia 2003 and 2005 (ACAM 2003; 2005a). More recently, 
ACAM have used newly available PBS data that links the prescription history of individuals 
and includes their basic demographic characteristics. This has been published in the report: 
Patterns of asthma medication use in Australia (ACAM 2007b). These data were able to assess 
the use of the main ‘preventer’ medication, inhaled corticosteroids, and disaggregate data by 
age group, sex, socioeconomic status and remoteness of residence. However, they were not 
able to identify those individuals who were prescribed the treatment specifically for asthma.  
More recent NHS data have been reported in ACAM’s report: Asthma in Australia: findings 
from the 2004–05 National Health Survey (ACAM 2007a).  
Summary of findings 
The data consistently suggest that many people with asthma who would benefit from using 
inhaled corticosteroids do not use them regularly. Analysis of individuals in PBS data 
identified that most people who purchased inhaled corticosteroids only filled one to three 
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prescriptions over a two-year period. Also, the majority of inhaled corticosteroids were 
taken in the most potent formulation. It is likely that, for many people, their asthma could be 
well controlled with less potent inhaled corticosteroids that carry fewer risks of side effects. 
The majority of inhaled corticosteroids are now administered in a combined formulation 
with long-acting beta agonists. This should also allow the use of lower potency of inhaled 
corticosteroids, with equivalent efficacy.  
Inhaled corticosteroids were used more than twice as much among people who obtained 
them at a concessional rate, which suggests that the price of these medications impedes their 
regular use by many individuals (ACAM 2007b). 
Data development issues 
The data sources for this indicator require development so that use of medications for 
asthma can be more accurately ascertained. Questions have been proposed in the 
recommended module of survey questions to monitor national asthma indicators that would 
obtain self-reported measures of medication use for acute asthma (ACAM 2007c). 
2.23  The proportion of people with asthma who 
have had recent spirometry 
Operational definition  
Numerator: Number of claims for spirometry in a given year for people with asthma. 
Denominator:  Total number of people with current asthma. 
Data sources 
Limited information relating to this indicator has been reported in Asthma in Australia 2003 
and 2005 (ACAM 2003; 2005a) using claims data from the Medicare Benefits Scheme. A 
major limitation of these data is that there is no clinical information that enables the 
identification of spirometry that was performed for asthma as opposed to other respiratory 
conditions. This is particularly a problem among older people who may have spirometry to 
assess COPD. Therefore data were separately presented in these reports for people aged 5 to 
34 years, for whom it was highly probable that spirometry was used in the management of 
asthma. 
Summary of monitoring activities 
Available data relating to this indicator were reported in Asthma in Australia 2003 and 2005 
(ACAM 2003; 2005a). These analyses presented information about the overall use of 
spirometry based on claims for these services in Australia. Time trends since 1994 were 
provided and differentiated between lab-based and office-based claims. The most recent 
three years of data were disaggregated by age, sex, state, and socioeconomic status. As it was 
not possible to differentiate claims made for asthma, data were presented as a rate per 
100,000 population rather than as a proportion of people with asthma. In addition, 
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subsidiary analyses were carried out to estimate the rate of spirometry among people aged  
5 to 34 years because this subgroup would have been most likely to have had the procedure 
for asthma rather than some other chronic respiratory condition. 
Summary of findings 
Most claims for spirometry occur in the winter months. Between 1994 and 2004, spirometry 
claims decreased slightly, particularly among people aged 5 to 34 years. This decrease was 
mainly observed among office-based spirometry, while laboratory-based spirometry (which 
comprise a minority of all claims) increased. 
The highest rate of spirometry was among elderly people aged 65 to 84 years among whom 
it was more common among males than females. Spirometry was also more common among 
boys than girls; however, among people aged 15 to 64 years, spirometry was more common 
among women.  
There was substantial variation between states and territories in spirometry rates. 
Data development issues 
At present the indicator is not measurable in the recommended form. Data on Medicare 
Benefits Schedule (MBS) claims for the performing spirometry are available, but it is not 
possible to separately identify the occasions of service for the performance of spirometry in 
people with asthma. 
Development of a data source that is able to determine when spirometry is performed for the 
assessment of asthma, rather than for other respiratory conditions, is needed if this indicator 
is to be monitored accurately. At the time of this review, plans for enhancing the currently 
available data source were not under development. 
2.24  Costs of asthma 
Operational definition  
This is a composite indicator that uses data from a range of sources. 
Data sources 
Two data sources have been used for this indicator; the AIHW National Health Expenditure 
Database, and data from the Australian Burden of Disease Study. 
Summary of monitoring activities 
ACAM have produced a report: Health care expenditure and burden of disease due to asthma in 
Australia (ACAM 2005c) which covers the above data sources. Expenditure data were also 
included in Asthma in Australia 2005 (ACAM 2005a). These data were examined by age, sex 
and health-care sector. 
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Summary of findings 
In the 2000–01 financial year, health expenditure on asthma was $693 million. This was 1.4% 
of total health expenditure in that year. Over half (54%) of expenditure allocated to asthma 
in 2000–01 was attributed to pharmaceuticals. The proportion of health expenditure 
attributed to asthma care was highest (over 25%) among children; particularly boys aged 5 to 
14 years.  
Overall, health expenditure on asthma increased by 21% between 1993–94 and 2000–01 
(adjusted to 2000–01 dollar values). However, expenditure for asthma due to GPs and 
specialists decreased. 
The Australian Burden of Disease Study estimated that asthma was the leading contributor 
to burden of disease among children aged 0 to 14 years—accounting for an estimated 18% of 
disability adjusted life years in this age group in 1996. The estimated financial equivalent of 
the burden of disease in Australia due to asthma in 1996 was $4.3 billion (2000–01 dollars).  
Data development issues 
The ability to carry out a formal economic analysis of the costs of asthma is currently beyond 
the role of monitoring using routinely available data sources and further development of 
this indicator is needed to ensure its intent is clear. 
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3 Review of data development activities 
In 2005, a detailed asthma data development plan was released (ACAM 2005b), which 
outlined a range of projects that would address the data deficiencies for monitoring the 
recommended asthma indicators. These projects were grouped into a number of areas that 
would engage specific collaborations including:  
• development of survey questions 
• data linkage 
• validation of coding (hospital and mortality data) 
• development of general practice data 
• further investigation into dynamic health assessment to study health outcomes 
• working with multiple cause of death and with multiple diagnosis hospital data 
• input into national data development processes. 
Here, these project areas are reviewed to evaluate the extent to which the data development 
plan has been implemented. 
3.1 Survey questions  
In 2004, ASMA implemented a process of survey question development to identify reliable 
and valid questions that can be used in health surveys to monitor the recommended asthma 
indicators. This process involved key groups including the ABS and CATI Health survey 
experts. The following indicators were considered in this process: 
• prevalence of ever having diagnosed asthma 
• prevalence of recent wheeze 
• rate of exacerbations of asthma 
• number of people with current asthma who have an asthma action plan  
• impact of asthma on quality of life 
• asthma control in people with current asthma 
• prevalence of smoking in the household where children with asthma reside 
• prevalence of smoking in people with current asthma 
• proportion of people with current asthma who use ‘preventers’ regularly. 
The process involved a detailed review of available survey questions, development of new 
questions where existing questions were not available, and testing of questions for which 
reliability was uncertain. The outcome was a recommended module of questions for 
monitoring Australian asthma indicators (ACAM 2007c). 
It is expected that the implementation of the asthma question module in a range of surveys 
will facilitate improved data for asthma monitoring as well as strengthen comparisons 
between surveys. Already a number of key surveys have agreed to adopt these 
recommendations. The ABS have indicated that they will include the recommended question 
for the ‘Prevalence of current asthma’ in the 2007–08 NHS to monitor current asthma. The 
previous question used by the NHS will also be asked, so that the difference in estimates of 
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current asthma obtained by each question can be evaluated. The New South Wales Health 
Survey program has also indicated that they will implement most of the recommended 
questions in their asthma modules in future health surveys. 
The module of recommended questions has been included in Appendix A of this report. 
3.2 Data linkage 
While survey data are a key source of information for monitoring several national asthma 
indicators, there are important limitations in the use of surveys including:  
1)  most measurements are based on self-report. 
2)  an increasing problem with low response rates in community-based surveys leading to 
possibly biased results. 
3)  surveys are expensive to implement.  
Alternative data sources are required to complement the data obtained from surveys. One 
approach has been to use routinely collected administrative health data, such as 
hospitalisation and mortality statistics. In addition to their administrative purposes, these 
data may provide valuable epidemiological information. They have the advantage of being 
readily available and are usually complete, or nearly complete. The main disadvantage is 
that, because these data have been collected for administrative purposes, they are often not 
ideal for use as a source of epidemiological information. Furthermore, they represent a 
limited range of information about the burden and management of asthma in the 
community. 
One way of enhancing the value of routinely collected administrative data has been to link 
information from related data sets and also to link data for individuals within data sets (Hall 
et al. 2005). Data linkage is a potentially powerful and cost effective means of achieving 
health research goals, provided consideration is given to ensuring that individual privacy is 
not compromised. To contend with this, anonymous linkage methods have been developed 
that might increase the feasibility of this approach to research (Kelman et al. 2002).  
There are two recommended asthma indicators for which data linkage would be relevant. 
Both relate to hospital admissions: 
• 2.15  Hospital re-admissions for asthma 
• 2.16  Number of individuals with separations for asthma. 
In Australia, hospitalisation records are based on hospital separations, rather than on the 
individuals hospitalised. In order to monitor indicators 2.15 and 2.16, hospitalisation records 
for the same person need to be linked to observe ‘people’ rather than hospital separations. 
This requires that the data contain suitable information to be able to group records that 
pertain to the same individual, such as a unique number for each person, or personally 
identifying information such as name, address and date of birth. State-level hospital data 
include personally identifying information that can be used to ‘link’ records of the same 
person with a high level of accuracy. Several states already undertake hospital record 
linkage on either a routine or ad hoc basis (for example, New South Wales, Victoria and 
Western Australia). 
However, for national monitoring purposes, it is desirable to identify a single national 
source of data. The most obvious is the NHMD because it contains hospital data forwarded 
from all states and territories. However, the information in this data set is more limited than 
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that held by the states and does not include variables such as names and addresses that 
would typically be used in data linkage.  
A major undertaking in this area by ACAM has been to investigate whether, with the more 
limited range of variables, it is still possible to link hospital separations that pertain to the 
same person in the NHMD. To do this, ACAM carried out a study in New South Wales 
using state hospitalisation data. This study compared linkage that used all available 
personally identifying information (that is names, addresses, dates of birth and other 
variables) with a ‘restricted’ linkage method that used only those variables that are 
forwarded to the NHMD (that is date of birth, postcode and sex) (Ringland et al. 2006). This 
study was applied only to records in which the principal diagnosis code was asthma, and 
found that over 95% of records identified by the first method were also identified in the 
restricted linkage method.  
The results of ACAM’s study suggest that hospital re-admissions for asthma can be reliably 
monitored using the NHMD. The next stage will be to implement this method in the 
NHMD, and approval has been given by all states and territories except Queensland to do 
this. If this is successfully implemented, it will provide a national data source for monitoring 
the relevant asthma indicators. 
Linkage has also been used in analysing the data from the PBS database to investigate the 
patterns of use of asthma medications in Australia. Since early 2002, PBS prescriptions have 
included the patients’ Medicare numbers. Use of the Medicare number, which is encrypted 
to protect patient confidentiality, has created the ability to anonymously identify 
prescriptions for the same individuals within the PBS data and also to link information on 
age, sex and home postcode. ACAM obtained these data from the DoHA for people who 
were prescribed asthma medications during the period July 2002 to July 2004 and the results 
of the analysis were presented in the report Patterns of asthma medication use in Australia, 
published in May 2007 (ACAM 2007b). 
3.3 Validation of coding 
As already stated, administrative health data are a valuable source of data for monitoring a 
range of the agreed national asthma indicators, particularly hospital and mortality data. The 
variables within these data sets use codes from the International Classification of Diseases 
(ICD). These are essential for selecting records that pertain to people with asthma.  
As such, the quality of coding across the range of data sets is critical for ensuring accuracy of 
the information obtained from these sources. Coding of hospital and mortality data is 
carried out by individuals trained in coding. The standards for coding hospital and mortality 
data are managed in Australia by the National Centre for Classification in Health (NCCH). 
With each revision of ICD, an associated set of ‘coding rules’ is provided to direct 
professional coders in the application of the codes. The NCCH also releases additional 
guidelines to ensure that coders interpret the coding rules consistently in all jurisdictions. 
The ICD is reviewed regularly and updated. Currently in Australia, mortality data are coded 
using the 10th revision of ICD (ICD-10) and hospital data are coded using the Australian 
Modification of the 10th revision of ICD, (ICD-10-AM).  
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Comparability factors 
ICD-10 replaced ICD-9 in Australia in the late 1990s at different times in various 
jurisdictions. During the transition period, dual coding projects were undertaken so that the 
impact of the revised ICD could be assessed. A change in ICD-10 rules, from the previous 
ICD-9, was that death certificates and hospital records that included both asthma and COPD 
were more likely to be coded to COPD, rather than asthma. ACAM obtained dual coded 
hospital and mortality data for asthma diagnoses to assess the impact of this change. This 
study found that the change from ICD-9 to ICD-10 had a substantial impact on asthma 
mortality and hospital separations data for persons aged over 35 years, but not for younger 
people (Baker et al. 2003). ACAM were able to use these data to calculate comparability 
factors for three broad age groups:  5 to 34 years: 1.0; 35 to 64 years: 0.84; and 65 years or 
over: 0.68. Time trends that span the period when ICD-9 changed to ICD-10 can be adjusted 
by multiplying data coded in ICD-9 by these comparability factors. It is now recommended 
that these be applied to time series analyses of hospital and mortality data that span across 
both ICD revisions so that trends are represented consistently over time (Baker et al. 2004). 
Review of asthma codes 
In 2005, a review by the NCCH of the ICD-10 and ICD-10AM codes used for asthma found 
that there were limitations in the ability of these codes to provide information about the 
types of asthma that may have clinical relevance. The NCCH proposed further study to 
investigate how medical practitioners record patient information relating to asthma with a 
view to making recommendations to improve the codes for asthma. This would inform 
submissions into future revisions of ICD. ACAM have been invited to provide consultation 
and advice on this activity. 
3.4 Other data development 
General practice data 
GPs play a central role in managing asthma in the community. This role includes 
assessment, prescription of regular medications, education and review, as well as managing 
acute exacerbations.  
Currently the BEACH survey has provided the most detailed source of data about general 
practice activity in Australia. A sub-component of this survey are the SAND (Supplementary 
Analysis of Nominated Data) modules. While the data items collected in the BEACH survey 
are stable over time, SAND modules can be commissioned by organisations to survey issues 
of interest.  
It may be possible for ACAM to develop a SAND module to collect further information 
about a number of indicators, including inhaled corticosteroid use, asthma severity and 
asthma action plans. However, some caution is needed in the use of SAND modules 
particularly in relation to the prescription of inhaled corticosteroids and the use of written 
asthma action plans. As noted in the review of asthma indicators, these may incur bias due 
to the Hawthorne effect (that is, the reporting GPs may be influenced by the survey itself to 
provide asthma action plans or prescribe inhaled corticosteroids) (Baker et al. 2004). This 
might be addressed by collecting information retrospectively, such as ‘before this visit, did 
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the patient have a written asthma action plan/was the patient prescribed regular inhaled 
corticosteroids?’ 
The major limitation of BEACH and SAND data is that this survey has low response rates 
and limited coverage. It is also not possible to distinguish general practice visits for routine 
asthma maintenance from those for acute asthma episodes. ACAM carried out a study to see 
if a combination of the variables available in BEACH among asthma-related records could 
identify a subgroup of those with evidence of acute asthma (Belousova et al. 2005). This 
study was not able to identify such a combination of variables. 
Given the importance of GPs in managing asthma and the limitations of existing data on 
primary care, developing new mechanisms for systematic collection of such data is crucial 
for monitoring asthma indicators relevant to policy and practice. Virtually all GP 
consultations are claimed on the Medicare Benefits Scheme. However, there is minimal data 
reported through this scheme. The data set does not include any information about the 
reason for the consultation or the actions undertaken. In the future, it may be possible to 
include additional information or link Medicare Benefits Scheme data with other data 
sources such as the PBS data set, hospital morbidity data and mortality data. This will 
require collaboration among the jurisdictions responsible for these data.  
Dynamic health assessment 
In the report: Measuring the impact of asthma on quality of life in the Australian population  
(ACAM 2004) dynamic health assessment was discussed as an option for improving the 
precision of questionnaire measures, particularly those used to measure complex health 
outcomes such as quality of life and asthma control. 
This approach contrasts with standard questionnaire approaches in which the same 
questions are administered to every person every time the instrument is used. Practical 
considerations in this approach dictate that relatively few questions are used in many health 
applications. This limits the precision that the questions can achieve, and may have 
problems with ceiling and floor effects whereby respondents are over-represented at the 
extreme ends of the scale (such as when most individuals respond ‘none’ or ‘always’ to a 
question).  
Dynamic health assessment seeks to address these limitations and implement questionnaires 
more efficiently by using only those questions that are relevant to the individual. A way to 
achieve this is by basing subsequent questions on the responses to earlier questions (Hays et 
al. 2000). To do this, technology is used to select individually tailored questions from a large 
pool of potential questions. This enables increased sensitivity and precision with far fewer 
questions being asked.  
As this is a developing area, the strengths and limitations of dynamic health assessment are 
probably not yet fully realised or understood, ACAM have recommended further 
investigation of this approach as a population monitoring tool (Baker et al. 2004). However, 
whether or not this will be a feasible approach to use in population health surveys in 
Australia is yet to be determined and currently this activity has not progressed. 
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Multiple diagnosis data 
As well as the principal diagnosis in hospitalisation data, additional diagnoses are included 
in routinely collected data that relate to the hospital admission. In a similar vein, mortality 
data include both the underlying cause of death and also other associated causes of death. 
These data may be of use either for population monitoring in asthma, particularly where 
there is overlap in diagnosis such as between asthma and COPD in older people. ACAM 
investigated the potential of these data in its report: Asthma and chronic obstructive pulmonary 
disease among older people in Australia (ACAM 2006). It found that while there was limited 
overlap between asthma and COPD, this may be a result of the requirements of ICD-10 
coding rules rather than an inherent lack of overlap. Unfortunately, there were no dual 
coded data for multiple diagnoses and causes of death. The study did, however, identify a 
number of other interesting disease associations with both asthma and COPD, such as 
increased rates of musculoskeletal disease associated with asthma. Further work in this area 
is warranted. 
Airway hyperresponsiveness data 
The prevalence of airway hyperresponsiveness was recommended for inclusion in the set of 
national asthma indicators as the only measure of the prevalence of asthma that is 
completely objective and uninfluenced by labelling or diagnostic fashion (Baker et al. 2004). 
Measurement of airway hyperresponsiveness requires the performance of a bronchial 
challenge test. A range of challenge protocols are in current use (American Thoracic Society 
2000).  Substantial development is required to agree on a specific challenge protocol and a 
methodology for its use in population monitoring and surveillance. As this indicator was not 
likely to be able to be monitored in the foreseeable future, it was not included in ACAM’s 
data development plan. 
However, ACAM have since developed a detailed proposal for an Australian asthma survey 
that would include a number of objective measurements including bronchial challenge 
testing. Including this measure adds considerably to the complexity of the study design 
because it requires that participants attend a local testing centre and consequently increases 
the requirement for a clustered sample design. It also adds substantially to the cost of the 
survey. Nonetheless data on airway hyperresponsiveness would be very advantageous for 
monitoring asthma. At the time of this review, options for funding the proposed asthma 
survey are being considered. 
Input into national data development 
National Data Dictionary 
A number of the operational definitions from the review of indicators (Baker et al. 2004) 
were recommended for inclusion in the National Data Dictionary. The submission of these 
definitions for formal inclusion in the National Data Dictionary is scheduled into the 
upcoming ASMA workplan, which runs from July 2007 to June 2009. 
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National emergency department minimum data set 
Currently emergency department data are only available in some jurisdictions and coverage 
within those jurisdictions is incomplete. The emergency department is an important point of 
health-care use for asthma. Usually it reflects cases of acute asthma, although often these do 
not progress to a hospital admission. Therefore, the absence of national emergency 
department data may leave a substantial gap in our ability to monitor health service use for 
acute asthma. Further work is needed in collaboration with health jurisdictions and the 
AIHW to develop a national emergency department minimum data set. 
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4 Future directions 
4.1 Ongoing monitoring 
The major undertaking for monitoring asthma indicators to date has been the production of 
the key reports: Asthma in Australia 2003 (ACAM 2003) and Asthma in Australia 2005 (ACAM 
2005a). These reports have brought together data from a wide range of sources to describe 
the current status of asthma in Australia. These documents mainly focused on reporting 
information for national asthma indicators and included information on the prevalence of 
asthma, medication use for asthma, possession of written asthma action plans, health service 
use and deaths due to asthma.  
The 2005 report also included information about health care expenditure for asthma and a 
focus chapter on asthma in Australian children. Both of these reports drew on data from the 
2001 NHS for a substantial proportion of the information presented. Therefore, a 
supplementary report: Asthma in Australia: findings from the 2004–05 National Health Survey 
was produced to provide updated information once data from the more recent NHS was 
available. The next report planned will be Asthma in Australia 2008. 
ACAM will continue to produce these reports that deliver information on national asthma 
indicators in an accessible format. In 2006, ACAM made available a more readily accessible 
version of Asthma in Australia 2005 with the inclusion of the html version on the ACAM web 
site. This online version allows quick and easy movement between chapters with links to the 
figures and tables. Some additional features of the online report are that all data tables have 
been included with the figures and there is updated trend data.  
A number of specific priorities identified by ASMA in the coming period may be addressed 
through individual projects. One of these is to collate additional information about asthma in 
children. Given the high level of disease burden attributed to asthma among children in 
Australia, this is an important area for policy and intervention. Therefore, a project is 
planned that will use a range of data sources that pertain to children to provide information 
about the impact of asthma in this population. 
Another area is the appropriate use of pharmaceuticals to manage asthma. ACAM have 
already undertaken substantial work using PBS data. The next phase of ASMA work will 
extend this by using PBS data that range over a longer time period to investigate time trends 
and patterns of incident use of asthma medications. 
It is important to note here that the list of asthma indicators needs to be periodically revised 
to ensure that they remain relevant for national monitoring. Some indicators may become 
obsolete with the evolution of knowledge and with changes in asthma-related public health 
and clinical practice. With the nature of the ageing population, it will also be important to 
consider the relevance of other conditions or comorbidities, which may influence outcomes, 
and hence indicators, in people with asthma.  
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4.2 Refining asthma indicators 
Health indicators are measures of selected aspects of health and the health system that can 
be used to monitor the effectiveness and impact of the health system and of specific 
interventions to improve health and provide effective, accessible and quality health care.  
Disease-specific indicators, such as those for asthma, summarise data that allow the regular 
reporting of disease levels, burden and trends and can be used to monitor changes over time. 
They are used to examine social, geographical and environmental differentials that may 
influence the development and burden of asthma.  
As already stated, an important function of indicators is to track the impact of health policy, 
and prevention and management strategies and to monitor progress towards targets.  
In its report: Review of proposed national health priority area asthma indicators and data sources 
(Baker et al. 2004); ACAM recommended 24 asthma indicators for inclusion in the Australian 
System for Monitoring Asthma. Experience with the use of these indicators has led us to the 
conclusion that there is a need to review them. Some are no longer relevant to policy needs. 
Others are redundant: providing information that is closely correlated with other indicators. 
Finally, some indicators will not be feasible to measure in the foreseeable future. The 
complexity of monitoring and reporting on many indicators makes it desirable to simplify 
the monitoring system where possible. This is likely to have the benefits of making 
information easier for target audiences to interpret. 
It is therefore worthwhile to refine the current set of asthma indicators and identify those 
that provide the most information or which are most effective at signalling change. ACAM 
propose to adopt a systematic approach with two components to revise the existing set of 
indictors:  
• Factor Analysis to identify domains of factors (that is, clusters of indicators) from data 
collected on the current indicators  
• A modified Delphi Survey of experts to solicit consensus opinions by ranking and 
reducing the existing list to a shorter, higher priority list of indicators. 
The factor analysis will yield a recommended set of independent indicators with robust 
statistical properties and the expert consensus opinions will ensure clinical relevance of the 
indicators. The key asthma indicators identified as a result of this process will provide high 
quality information on asthma in the population.  
These indicators will help ensure greater consistency in the provision of health services to 
individuals with asthma; to provide important support and justification for future human 
resource planning; and to inform and assist policy and decision-makers in addressing future 
asthma health resource planning and allocation requirements. 
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Appendix A  
Table A1: Recommended questions to monitor selected national asthma indicators 
Indicator Recommended questions Response categories 
Prevalence of recent 
wheeze 
1: Have you had wheezing or whistling in your chest at any time 
in the last 12 months? 
Yes 
No 
Prevalence of ever having 
diagnosed asthma 
2: Have you ever been told by a doctor or a nurse that you have 
asthma? If yes, 
Yes 
No 
Prevalence of current 
asthma 
2a: Have you had symptoms of asthma or taken treatment for 
asthma in the last 12 months?  
Yes 
No 
3: At any time in the last 12 months, was your asthma worse or 
out of control? If yes, 
Yes 
No 
3a: In the last 12 months, how many times have you gone to a 
hospital or emergency department because your asthma was 
worse or out of control?  
Number of times 
None / No times 
Rate of exacerbations of 
asthma 
3b: In the last 12 months, how many times have you consulted a 
GP or local doctor because your asthma was worse or out of 
control?   
Number of times 
None / No times 
Number of people with 
current asthma who have 
an action asthma plan 
4: Do you have a written asthma action plan, that is, written 
instructions of what to do if your asthma is worse or out of 
control?  
Yes 
No 
5.1: During the last 4 weeks how often did your asthma interfere 
with your daily activities? 
All of the time 
Most of the time 
Some of the time 
None of the time 
5.2: Sydney Asthma Quality of Life Questionnaire (20 items) Full questionnaire reproduced in  
Appendix A of ACAM 2007c 
Impact of asthma on quality 
of life(a) 
5.3: Paediatric Asthma Quality of Life Questionnaire (23 items) Permission required for use from 
Elizabeth Juniper 
<www.qoltech.co.uk> 
6.1: In the last 12 months, has wheezing ever been severe 
enough to limit your speech to only one or two words at a time 
between breaths?  
Yes 
No 
6.2: In the last 4 weeks, how often did you have symptoms of 
asthma; that is wheezing, chest tightness, coughing or 
shortness of breath?  
Every day 
3 or more times a week 
1 to 2 times a week 
Less than once a week 
6.3: In the last 4 weeks, have you been woken by asthma or 
wheezing? If yes, 
Yes 
No 
6.3a: In the last 4 weeks, how many nights have you been 
woken by asthma or wheezing?  
Number of times 
None / No times 
Asthma control in people 
with current asthma 
6.4: See also questions 9 and 9a. These questions will be used 
to assess the use of reliever medications as an indicator of 
asthma control. 
 
(continued) 
40 
 
Table A1 (continued): Recommended questions to monitor selected national asthma indicators 
Indicator Recommended questions Response categories 
Prevalence of smoking in 
the household where 
children with asthma 
reside(b) 
7: Which of the following best describes your home 
situation?  
My home is smoke free 
People occasionally smoke in the 
house 
People frequently smoke in the 
house 
8: Do you currently smoke? If yes, Yes 
No 
Prevalence of smoking in 
people with current 
asthma(b) 
8a: Do you smoke at least once a week? Yes 
No 
9: What are the names or brands of all the asthma 
medications you have used in the last 4 weeks? 
If any medications identified: 
Interviewers will have an updated 
list of currently available asthma 
medications. All responses in the 
list to be checked. Medications 
stated but not in the list to be 
recorded under ‘other’ 
Proportion of people with 
current asthma who use 
preventers regularly 
9a: How often did you use {name of medication} in the last 4 
weeks? (loop for each type of medication)  
For this indicator, these questions will be used to assess the 
frequency of use of preventer medications. 
Every day 
3 or more times a week 
1 to 2 times a week 
Less than once a week 
Not at all 
(a) Only asthma-specific health-related quality of life measures have been included in this asthma module. However, generic quality of life 
measures may also be used in many surveys that, when used in conjunction with the questions identifying people with current asthma, can 
be useful for making comparisons between people with and without asthma. 
(b) These questions are not asthma-specific and, for asthma monitoring purposes, would need to be used in conjunction with the questions 
identifying people with current asthma. However, the selected questions were included in the asthma module because they are able to 
measure the established asthma indicator consistently with its operational definition.   
 
 
 
 
